Skip to content

Live Events

Live Events

Live Events

Live Events

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,901 - 1,925 of 2,995

«
1
…
75
76
77
78
79
…
120
»

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC

By: Karen Kelly, MD

How I treat Stage III NSCLC

How I treat Stage III NSCLC

By: Karen Kelly, MD

How I treat Stage III NSCLC

How I treat Stage III NSCLC

By: Karen Kelly, MD

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

By: Karen Kelly, MD

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

By: Karen Kelly, MD

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

By: Karen Kelly, MD

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

By: Karen Kelly, MD

How to Start a Lung Cancer Screening Program

How to Start a Lung Cancer Screening Program

By: Karen Kelly, MD

How to Start a Lung Cancer Screening Program

How to Start a Lung Cancer Screening Program

By: Karen Kelly, MD

Adjuvant Therapies in NSCLC

Adjuvant Therapies in NSCLC

By: Karen Kelly, MD

Immunotherapy for Advanced NSCLC

Immunotherapy for Advanced NSCLC

By: Karen Reckamp, MD

KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors

KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors

By: Karen Reckamp, MD

KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors

KRAS: Deciphering the Mechanism of Resistance To First Generation KRAS Inhibitors

By: Karen Reckamp, MD

Which Patients Need Adjuvant Therapy?

Which Patients Need Adjuvant Therapy?

By: Karen Reckamp, MD

Immunotherapy for Advanced NSCLC

Immunotherapy for Advanced NSCLC

By: Karen Reckamp, MD, MS

Palliative Care Approaches in Lung Cancer

Palliative Care Approaches in Lung Cancer

By: Kavitha Ramchandran, MD

Palliative Care Approaches in Lung Cancer

Palliative Care Approaches in Lung Cancer

By: Kavitha Ramchandran, MD

Palliative Care Approaches in Lung Cancer

Palliative Care Approaches in Lung Cancer

By: Kavitha Ramchandran, MD

Palliative Care Approaches in Lung Cancer

Palliative Care Approaches in Lung Cancer

By: Kavitha Ramchandran, MD

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

By: Ken Yoneda, MD

Toxicity Management of Novel Agents in Lung Cancer

Toxicity Management of Novel Agents in Lung Cancer

By: Khurrum Qureshi, PharmD

Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)

Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)

By: Khurrum Qureshi, PharmD, BCOP

Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)

Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)

By: Khurrum Qureshi, PharmD, BCOP

Stage III NSCLC – Surgical/Combined Modality

Stage III NSCLC – Surgical/Combined Modality

By: Leah Backhus, MD

Stage III NSCLC – Surgical /Combined Modality

Stage III NSCLC – Surgical /Combined Modality

By: Leah Backhus, MD

«
1
…
75
76
77
78
79
…
120
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok